Welcome to Hisun Pharmaceuticals USA
Hisun Pharmaceuticals USA, established in 2009, is an emerging pharmaceutical company committed to the development, manufacture and commercialization of pharmaceutical products for the US market place with a focus on APIs, Generics, Specialty and Animal Health Products. Hisun USA also provides contract manufacturing services through its parent company Zhejiang Hisun Pharmaceutical Co. Ltd.
Zhejiang Hisun Pharmaceutical Co. Ltd., established in 1956, is headquartered in Taizhou, China with more than 7,000 employees. Zhejiang Hisun Pharmaceutical Company is one of the largest Active Pharmaceutical Ingredient (API) manufacturers in China. Our API products are shipped to our partners throughout the world. Zhejiang Hisun Pharmaceutical also manufactures finished dosage pharmaceuticals – capsules, tablets and parenterals – for Anti-Infective, Cardiovascular, Oncology, CNS, Animal Health and other therapeutic areas. Zhejiang Hisun Pharmaceuticals also has Antibody Drug Conjugate (ADC) and biosimilar manufacturing facilities.
Hisun USA is well positioned for growth in the United States, supported by our state-of-the-art facilities, manufacturing expertise, research and development capabilities.
News & Events
- ECRM 02/27/ 2017
- DCAT WEEK 03/20/ 2017
- The Protein Engineering Summit (PEGS) Boston 05/01/ 2017
- InformEx 05/16/ 2017
- Convention of Pharmaceutical Ingredients (CPhI) North America 05/16/ 2017
- Generic Pharma Association CMC Workshop 05/23/ 2017
- HDA 2017 Business and Leadership Conference 06/11/ 2017
- 2017 BIO International Convention 06/19/ 2017
- Convention of Pharmaceutical Ingredients (CPhI)- China 06/20/ 2017
- 7th World ADC San Diego 09/20/ 2017